The number of overweight people has been increasing rapidly in recent years due to genetic, socio-economic, lifestyle, and cultural influences
But real-world stories tell a different tale
It has shown significant promise as an effective intervention against type 2 diabetes (T2D) and excessive body weight, resulting in the United States Food and Drug Administration (FDA) approving its use against both conditions in May 2022 for T2D and November 2023 for obesity
It also targets other cells in the pancreas to stop the glucagon signal for generating glucose in the liver.[ref] In clinical trials, GLP-1 RAs improved lipid profiles, increased satiety, slowed gastric emptying, reduced inflammation, and had neuroprotective effects.[ref] The slowing of gastric emptying and reducing inflammation may play a role in weight loss, along with the decrease in appetite and eating less
So on top of steady energy levels, you can also tackle your day with clarity and confidence
What doses of BPC-157 are available wholesale